Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Hearings on contact lens solution marketing suits against Alcon, Allergan set for June.

This article was originally published in The Gray Sheet

Executive Summary

ALCON, ALLERGAN PREEMPTION DEFENSE IN CONTACT LENS SOLUTION MARKETING LAWSUITS will be argued in hearings set for June 7 in the case of Nicholas v. Alcon and June 14 in Bruno v. Allergan. At the sessions, the California Superior Court in San Diego will hear arguments on the validity of the manufacturers' assertion that federal device law preempts the plaintiffs' claims of false advertising and unfair business practices.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT006036

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel